Balyasny Asset Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-833
| Closed | -$287K | – | 1422 |
|
|
2019
Q3 | $287K | Buy |
+833
| New | +$287K | ﹤0.01% | 900 |
|
|
2019
Q2 | – | Sell |
-370
| Closed | -$590K | – | 1622 |
|
|
2019
Q1 | $590K | Sell |
370
-2,376
| -87% | -$3.79M | ﹤0.01% | 1061 |
|
|
2018
Q4 | $5.13M | Buy |
2,746
+2,563
| +1,401% | +$4.79M | 0.04% | 448 |
|
|
2018
Q3 | $431K | Buy |
+183
| New | +$431K | ﹤0.01% | 1198 |
|
|
2018
Q2 | – | Sell |
-106
| Closed | -$300K | – | 2000 |
|
|
2018
Q1 | $300K | Sell |
106
-31
| -23% | -$87.7K | ﹤0.01% | 1424 |
|
|
2017
Q4 | $352K | Buy |
+137
| New | +$352K | ﹤0.01% | 1430 |
|
|
2016
Q1 | – | Sell |
-1,443
| Closed | -$7.41M | – | 1378 |
|
|
2015
Q4 | $7.41M | Sell |
1,443
-677
| -32% | -$3.47M | 0.05% | 378 |
|
|
2015
Q3 | $6.74M | Buy |
2,120
+1,174
| +124% | +$3.73M | 0.05% | 376 |
|
|
2015
Q2 | $3.79M | Buy |
+946
| New | +$3.79M | 0.02% | 480 |
|
|
2014
Q4 | – | Sell |
-1,077
| Closed | -$4.38M | – | 661 |
|
|
2014
Q3 | $4.38M | Buy |
+1,077
| New | +$4.38M | 0.03% | 335 |
|